Towards an AIDS vaccine: The role of primate models

International Journal of STD and AIDS

Volumn 9, Issue SUPPL. 1, 1998, Pages 3-7

  Nathanson, Neal ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD LEVEL; CONFERENCE PAPER; DRUG INDUSTRY; EPIDEMIC; EVALUATION AND FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; MEDICAL RESEARCH; MUCOSAL IMMUNITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PUBLIC HEALTH; SEMINAL PLASMA; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINE PRODUCTION; VIRUS LOAD;

EID: 0031774832     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Balter M. Impending AIDS vaccine trials opens old wounds. Science 1998;279:650
2. Bolognesi D, Matthews TJ. Viral envelope fails to deliver. Nature 1998;391:638-9
3. Connor RI, Korber BT, Graham BS, et al. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol 1998;72:1552-76
4. Graham BS, McElrath MJ, Connor RI, et al. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. J Infect Dis 1998;177:310-19
5. Levy JA. HIV and the Pathogenesis of AIDS. Washington: ASM Press, 1998
6. Stott JE, Almond N. Assessing animal models of AIDS. Nature Med 1995;1:295-6
7. Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70
8. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16
9. Cole KS, Rowles JL, Jagerski BA, et al. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997;71:5069-79
10. Cranage MP, Whatmore AM, Sharpe SA, et al. Macaques infected with live attenuated SIV mac are protected against superinfection via the rectal mucosa. Virology 1997;229:143-54
11. Johnson RP, Glickman RL, Yang JQ, et al. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 1997;71:7711-18
12. Shibata R, Siemon C, Czajak SC, Desrosiers RC, Martin MA. Live attenuated simian immunodeficiency viruses elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol 1997;71:8141-8
13. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70:3724-33
14. Arthur LO, Bess Jr JW, Sowder IIRC, et al. Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 1992;258:1935-8
15. Arthur LO, Bess Jr JW, Urban RG, et al. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995;69:3117-24
16. Cranage MP, Polyanskaya N, McBride B, et al. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retrovir 1993;9:13-22
17. Stott JE. Anti-cell antibody in macaques. Nature 1991;353:393
18. Stott JE, Schild GC. Strategies for AIDS vaccines. J Antimicrob Chemother 1996;37(Suppl B):185-98
19. Israel ZR, Edmonson PF, Maul DH, et al. Incomplete suppression, but suppression of viral burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol 1994;68:1843-53
20. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-8
21. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/ human immunodeficiency virus during primary infection of rhesus macaques. J Virol 1998;72:164-9
22. Simon MA, Brodie SJ, Sasseville VG, Chalifoux LV, Desrosiers RC, Ringler DJ. Immunopathogenesis of SIV mac. Virus Res 1994;32:227-51
23. Letvin NL, Montefiori D, Yasutomi Y, et al. Potent protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci (USA) 1997;94:9378-83
24. Zhang ZQ, Schuler T, Wietgrefe S, Reimann KA, Letvin NL, Haase A. Initial productive infection and cell tropisms in acute infection of rhesus monkeys with intravaginal inoculation of an uncloned SIV mac 251. Fifth International Conference on Retroviruses and Opportunistic Infections, 1998 (Abstract)
25. Heise C, Miller CJ, Lackner A, Dandekar S. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 1994;169:1116-20
26. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998;177:320-30